Department of Public Health, Tokushima University Graduate School of Biomedical Sciences.
Department of Epidemiology and Prevention, National Center for Global Health and Medicine.
J Atheroscler Thromb. 2022 Sep 1;29(9):1295-1306. doi: 10.5551/jat.63118. Epub 2021 Oct 23.
We aimed to investigate the association between non-high-density lipoprotein cholesterol (non-HDL-C) levels and the risk of cardiovascular disease (CVD) and its subtypes.
In this contemporary cohort study, we analyzed the data of 63,814 Japanese employees aged ≥ 30 years, without known CVD in 2012 and who were followed up for up to 8 years. The non-HDL-C level was divided into 5 groups: <110, 110-129, 130-149, 150-169, and ≥ 170 mg/dL. The Cox proportional hazards model was used to calculate the hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) for CVD and its subtypes associated with each non-HDL-C group, considering 130-149 mg/dL as the reference group.
During the study period, 271 participants developed CVD, including 78 myocardial infarctions and 193 strokes (102 ischemic strokes, 89 hemorrhagic strokes, and 2 unknowns). A U-shaped association between non-HDL-C and stroke was observed. In the analysis of stroke subtypes, the multivariable-adjusted HR (95% CI) for hemorrhagic stroke was 2.61 (1.19-5.72), 2.02 (0.95-4.29), 2.10 (1.01-4.36), and 1.98 (0.96-4.08), while that for ischemic stroke was 1.54 (0.77-3.07), 0.91 (0.46-1.80), 0.73 (0.38-1.41), and 1.50 (0.87-2.56) in the <110, 110-129, 150-169, and ≥ 170 mg/dL groups, respectively. Individuals with elevated non-HDL-C levels had a higher risk of myocardial infarction.
High non-HDL-C levels were associated with an increased risk of myocardial infarction. Moreover, high and low non-HDL-C levels were associated with a high risk of stroke and its subtypes among Japanese workers.
本研究旨在探讨非高密度脂蛋白胆固醇(non-HDL-C)水平与心血管疾病(CVD)及其亚型风险之间的关系。
本研究采用当代队列研究方法,分析了 2012 年无已知 CVD 且年龄≥30 岁的 63814 名日本员工的数据,随访时间最长达 8 年。non-HDL-C 水平分为 5 组:<110、110-129、130-149、150-169 和≥170mg/dL。采用 Cox 比例风险模型计算每个 non-HDL-C 组与 CVD 及其亚型相关的风险比(HR)及其相应的 95%置信区间(CI),以 130-149mg/dL 为参考组。
在研究期间,271 名参与者发生 CVD,包括 78 例心肌梗死和 193 例卒中(102 例缺血性卒中和 193 例出血性卒中和 2 例未知)。non-HDL-C 与卒中之间存在 U 型关联。在对卒中亚型的分析中,多变量校正后的 HR(95%CI)为出血性卒中 2.61(1.19-5.72)、2.02(0.95-4.29)、2.10(1.01-4.36)和 1.98(0.96-4.08),而缺血性卒中为 1.54(0.77-3.07)、0.91(0.46-1.80)、0.73(0.38-1.41)和 1.50(0.87-2.56),<110、110-129、150-169 和≥170mg/dL 组分别为。non-HDL-C 水平升高的个体发生心肌梗死的风险较高。
高 non-HDL-C 水平与心肌梗死风险增加相关。此外,日本工人中,高 non-HDL-C 和低 non-HDL-C 水平与卒中及其亚型风险升高相关。